Get started
AMPLIA THERAPEUTICS LIMITEDAMPLIA THERAPEUTICS LIMITEDAMPLIA THERAPEUTICS LIMITED

AMPLIA THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ATX chart


Full chart

Key stats


Market capitalization
‪20.17 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−4.50 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪360.30 M‬
Beta (1Y)
0.69

About AMPLIA THERAPEUTICS LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher J. Burns
Website
ampliatx.com
Headquarters
Melbourne
Founded
2013
ISIN
AU0000023822
FIGI
BBG005M56XX7
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. Its immuno-modulator microparticles technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as multiple sclerosis. The company was founded by Christopher J. Burns on May 31, 2000 and is headquartered in Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ATX news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ATX.

Frequently Asked Questions


The current price of ATX is 0.051 AUD — it has decreased by −1.92% in the past 24 hours. Watch AMPLIA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AMPLIA THERAPEUTICS LIMITED stocks are traded under the ticker ATX.
ATX stock has fallen by −8.93% compared to the previous week, the month change is a −30.14% fall, over the last year AMPLIA THERAPEUTICS LIMITED has showed a −13.56% decrease.
ATX reached its all-time high on Jan 27, 2017 with the price of 16.279 AUD, and its all-time low was 0.040 AUD and was reached on Mar 19, 2020. View more price dynamics on ATX chart.
See other stocks reaching their highest and lowest prices.
ATX stock is 5.88% volatile and has beta coefficient of 0.69. Track AMPLIA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is AMPLIA THERAPEUTICS LIMITED there?
Yes, you can track AMPLIA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
No, ATX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMPLIA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMPLIA THERAPEUTICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMPLIA THERAPEUTICS LIMITED stock shows the strong sell signal. See more of AMPLIA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.